性结肠炎由粒状炎症复杂化,并有多性结肠炎,并用塔克罗利慕斯治疗
Kazuya Miyaguchi1, Kaho Ishimoto1, Hisashi Matsumoto1
1Department of Gastroenterology, Saitama Medical University, Saitama 350-0451, Japan.
概括
这项案例研究突出了性结肠炎的罕见并发症:多性结肠炎的颗粒. 塔克罗利马斯与普雷迪尼索隆结合,有效治疗了这个患者,提供了一个新的治疗选择.
科学领域:
- 胃肠病学 胃肠病学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 带有多炎 (GPA) 的颗粒瘤病是一种罕见的全身性血管炎.
- 很少报告UC和GPA重叠导致的并发症.
研究的目的:
- 报告一种独特的性结肠炎病例,其并发症是由多性结肠炎的粒状结肠炎引起的.
- 描述这种罕见疾病的诊断发现和成功治疗.
- 为了突出塔克罗利斯作为潜在的治疗剂.
主要方法:
- 一名64岁的女性患者有UC病史,出现腹痛,胃肠道出血和紫外线.
- 诊断工作包括实验室测试 (CBC,炎症标志物,ANCA),CT扫描,结肠镜检查和皮肤活检.
- 治疗包括使用普得尼索隆和塔克罗利斯的免疫抑制疗法.
主要成果:
- 患者出现了贫血,炎症标志物升高,以及阳性蛋白酶3特异性ANCA.
- 影像和活检证实白细胞结晶性血管炎与GPA一致,影响胃肠道和皮肤.
- 在接受了普得尼索隆和塔克罗利斯治疗后,症状消失了.
结论:
- 这是首次报告成功治疗性结肠炎的塔克罗利斯病例,该病症由多性结肠炎的颗粒瘤症复杂化.
- 塔克罗利斯可能是治疗UC患者GPA的可行的治疗选择.
- 早期诊断和联合免疫抑制疗法对于有利的结果至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
473
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
473
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
420
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
420
Drugs for Treatment of Ulcerative Colitis in IBD
439
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
439
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
470
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
470
Pulmonary Tuberculosis I
816
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
816
Kidney Transplant II: Surgical Procedure
293
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
293


